Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement [1]
Five year results of the PARTNER II trial demonstrated no difference in the risk of stroke or death comparing TAVR to surgical aortic valve replacement among intermediate surgical risk patients.
Source name:
New England Journal of Medicine
Resource link:
Subspecialty(ies):
Cardiac [6]
Taxonomy2018 vocabulary term reference: